BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31811588)

  • 1. Protective Effect of (-)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats.
    Tseng HC; Wang MH; Chang KC; Soung HS; Fang CH; Lin YW; Li KY; Yang CC; Tsai CC
    Neurotox Res; 2020 Mar; 37(3):669-682. PubMed ID: 31811588
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chen CN; Wang MH; Soung HS; Chen SM; Fang CH; Lin YW; Tseng HC
    Neurotox Res; 2022 Feb; 40(1):241-258. PubMed ID: 34988886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms.
    Kumar P; Kumar A
    Psychopharmacology (Berl); 2009 Dec; 207(2):257-70. PubMed ID: 19763544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
    Farombi EO; Awogbindin IO; Farombi TH; Oladele JO; Izomoh ER; Aladelokun OB; Ezekiel IO; Adebambo OI; Abah VO
    Neurotoxicology; 2019 Jul; 73():132-141. PubMed ID: 30930291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.
    Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
    Drug Des Devel Ther; 2015; 9():5499-510. PubMed ID: 26504373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of epigallocatechin gallate on rotenone-injured murine brain cultures.
    Moldzio R; Radad K; Krewenka C; Kranner B; Duvigneau JC; Wang Y; Rausch WD
    J Neural Transm (Vienna); 2010 Jan; 117(1):5-12. PubMed ID: 19707849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.
    Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
    Neurotox Res; 2016 Feb; 29(2):275-87. PubMed ID: 26607911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic insights into the protective effect of paracetamol against rotenone-induced Parkinson's disease in rats: Possible role of endocannabinoid system modulation.
    Labib AY; Ammar RM; El-Naga RN; El-Bahy AAZ; Tadros MG; Michel HE
    Int Immunopharmacol; 2021 May; 94():107431. PubMed ID: 33578261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.
    Anusha C; Sumathi T; Joseph LD
    Chem Biol Interact; 2017 May; 269():67-79. PubMed ID: 28389404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-) Epigallocatechin-3-gallate attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum.
    Wang MH; Lin RF; Tseng HC; Soung HS; Chang KC; Tsai CC
    Pharmacol Biochem Behav; 2015 Apr; 131():71-6. PubMed ID: 25668129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide pathway activity modulation alters the protective effects of (-)Epigallocatechin-3-gallate on reserpine-induced impairment in rats.
    Chen CN; Chang KC; Lin RF; Wang MH; Shih RL; Tseng HC; Soung HS; Tsai CC
    Behav Brain Res; 2016 May; 305():198-211. PubMed ID: 26944334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.
    Javed H; Azimullah S; Abul Khair SB; Ojha S; Haque ME
    BMC Neurosci; 2016 Aug; 17(1):58. PubMed ID: 27549180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kolaviron protects against nigrostriatal degeneration and gut oxidative damage in a stereotaxic rotenone model of Parkinson's disease.
    Farombi EO; Awogbindin IO; Olorunkalu PD; Ogbuewu E; Oyetunde BF; Agedah AE; Adeniyi PA
    Psychopharmacology (Berl); 2020 Nov; 237(11):3225-3236. PubMed ID: 32651640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Protective Effect of Korean Red Ginseng Against Rotenone-Induced Parkinson's Disease in Rat Model: Modulation of Nuclear Factor-κβ and Caspase-3.
    Zaafan MA; Abdelhamid AM; Ibrahim SM
    Curr Pharm Biotechnol; 2019; 20(7):588-594. PubMed ID: 31198107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Potentials of Berberine in Rotenone-Induced Parkinson's Disease-like Motor Symptoms in Rats.
    Tseng HC; Wang MH; Fang CH; Lin YW; Soung HS
    Brain Sci; 2024 Jun; 14(6):. PubMed ID: 38928596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test.
    Madiha S; Haider S
    Metab Brain Dis; 2019 Feb; 34(1):297-308. PubMed ID: 30506334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease.
    Balakrishnan R; Vijayraja D; Mohankumar T; Manimaran D; Ganesan P; Choi DK; Elangovan N
    J Chem Neuroanat; 2021 Mar; 112():101890. PubMed ID: 33220427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanillin Attenuated Behavioural Impairments, Neurochemical Deficts, Oxidative Stress and Apoptosis Against Rotenone Induced Rat Model of Parkinson's Disease.
    Dhanalakshmi C; Janakiraman U; Manivasagam T; Justin Thenmozhi A; Essa MM; Kalandar A; Khan MA; Guillemin GJ
    Neurochem Res; 2016 Aug; 41(8):1899-910. PubMed ID: 27038927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine, a key factor of mitochondrial damage and neuronal toxicity on rotenone exposure and also parkinsonic motor dysfunction-Impact of asiaticoside with a probable vesicular involvement.
    Margabandhu G; Vanisree AJ
    J Chem Neuroanat; 2020 Jul; 106():101788. PubMed ID: 32278634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism.
    Reznichenko L; Kalfon L; Amit T; Youdim MB; Mandel SA
    Neurodegener Dis; 2010; 7(4):219-31. PubMed ID: 20197647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.